MCM2 and ovarian cancer: MCM2, a highly conserved minichromosome maintenance protein (MCM), is involved in the initiation of eukaryotic genome replication and is closely related to the prognosis of ovarian cancer patients and the sensitivity to chemotherapy [25–27].